{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Autoimmune+Hemolytic+Anemia", "query": { "condition": "Autoimmune Hemolytic Anemia" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 48, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Autoimmune+Hemolytic+Anemia&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-11T07:07:07.153Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05002777", "title": "Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Warm Autoimmune Hemolytic Anemia (wAIHA)" ], "interventions": [ { "name": "rilzabrutinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2021-12-07", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 11, "location_summary": "Cerritos, California • Glendale, California • Long Beach, California + 7 more", "locations": [ { "city": "Cerritos", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05002777" }, { "nct_id": "NCT01105923", "title": "Study of an Intervention to Improve Problem List Accuracy and Use", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Attention Deficit Disorder With Hyperactivity", "Asthma", "COPD", "Breast Cancer", "Coronary Artery Disease", "Congestive Heart Failure", "Diabetes", "Glaucoma", "Hemophilia", "Hypertension", "Hyperthyroidism", "Hypothyroidism", "Myasthenia Gravis", "Osteoporosis", "Osteopenia", "Renal Failure", "Renal Insufficiency", "Sickle Cell Disease", "Stroke" ], "interventions": [ { "name": "MAPLE", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2010-05", "completion_date": "2017-11", "has_results": false, "last_update_posted_date": "2015-02-02", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01105923" }, { "nct_id": "NCT00006055", "title": "Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Purpura, Schoenlein-Henoch", "Graft Versus Host Disease", "Anemia, Hemolytic, Autoimmune", "Rheumatoid Arthritis", "Churg-Strauss Syndrome", "Hypersensitivity Vasculitis", "Wegener's Granulomatosis", "Systemic Lupus Erythematosus", "Giant Cell Arteritis", "Pure Red Cell Aplasia", "Juvenile Rheumatoid Arthritis", "Polyarteritis Nodosa", "Autoimmune Thrombocytopenic Purpura", "Takayasu Arteritis" ], "interventions": [ { "name": "anti-thymocyte globulin", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cyclosporine", "type": "DRUG" }, { "name": "filgrastim", "type": "DRUG" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "Autologous Peripheral Blood Stem Cell Transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Fairview University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "55 Years", "sex": "ALL", "summary": "1 Year to 55 Years" }, "enrollment_count": 10, "start_date": "2000-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006055" }, { "nct_id": "NCT04253236", "title": "To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Warm Autoimmune Hemolytic Anemia" ], "interventions": [ { "name": "RVT-1401 680 mg/weekly", "type": "DRUG" }, { "name": "RVT-1401 340 mg/weekly", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Immunovant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2020-08-11", "completion_date": "2021-04-01", "has_results": true, "last_update_posted_date": "2022-07-28", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 5, "location_summary": "Iowa City, Iowa • Louisville, Kentucky • Boston, Massachusetts + 2 more", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Greenville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04253236" }, { "nct_id": "NCT03075878", "title": "A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Warm Autoimmune Hemolytic Anemia" ], "interventions": [ { "name": "ALXN1830", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2018-01-10", "completion_date": "2019-08-06", "has_results": true, "last_update_posted_date": "2020-05-13", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 9, "location_summary": "Los Angeles, California • San Francisco, California • Boston, Massachusetts + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Pittsfield", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03075878" }, { "nct_id": "NCT01758042", "title": "Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Kidney Disease", "Acute Myeloid Leukemia (AML)", "Acute Lymphoblastic Leukemia (ALL)", "Chronic Myelogenous Leukemia (CML)", "Chronic Lymphocytic Leukemia (CLL)", "Non-Hodgkin's Lymphoma (NHL)", "Hodgkin Disease", "Multiple Myeloma", "Myelodysplastic Syndrome (MDS)", "Aplastic Anemia", "AL Amyloidosis", "Diamond Blackfan Anemia", "Myelofibrosis", "Myeloproliferative Disease", "Sickle Cell Anemia", "Autoimmune Diseases", "Thalassemia" ], "interventions": [ { "name": "Haploidentical Bone Marrow/Kidney", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 10, "start_date": "2012-11", "completion_date": "2025-07", "has_results": false, "last_update_posted_date": "2026-03-06", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01758042" }, { "nct_id": "NCT00392951", "title": "Sirolimus for Autoimmune Disease of Blood Cells", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Autoimmune Pancytopenia", "Autoimmune Lymphoproliferative Syndrome (ALPS)", "Evans Syndrome", "Idiopathic Thrombocytopenic Purpura", "Anemia, Hemolytic, Autoimmune", "Autoimmune Neutropenia", "Lupus Erythematosus, Systemic", "Inflammatory Bowel Disease", "Rheumatoid Arthritis" ], "interventions": [ { "name": "sirolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "30 Years", "sex": "ALL", "summary": "1 Year to 30 Years" }, "enrollment_count": 30, "start_date": "2006-12", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2019-11-19", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00392951" }, { "nct_id": "NCT06098755", "title": "The Sequestration of Holistic Stress Management Techniques for Adults", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress, Job", "PTSD", "Hypervigilance", "Hyperthyroidism", "Migraine", "Migraine With Aura", "Immunodeficiency", "Sickle Cell Trait", "Sickle Cell Disease", "Anemia, Sickle Cell", "Anemia", "Fatigue", "Anxiety", "Depression", "Flat Feet", "Lordosis", "TBI (Traumatic Brain Injury)", "Rheumatoid Arthritis", "Arthritis", "Masturbation", "Priapism", "Erectile Dysfunction", "Flight Reaction", "Hypertension", "Sexual Arousal Disorder", "Hemorrhoids", "Fibroid" ], "interventions": [ { "name": "Holistic Medicine (HM)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Goddess Zena I. Jones", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 0, "start_date": "2026-01-26", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 1, "location_summary": "Anchorage, Alaska", "locations": [ { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06098755" }, { "nct_id": "NCT00001630", "title": "Treatment of Autoimmune Thrombocytopenia (AITP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autoimmune Disease", "Autoimmune Hemolytic Anemia", "Thrombocytopenia" ], "interventions": [ { "name": "Isolex 300i", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 29, "start_date": "1997-07-21", "completion_date": "2009-06-11", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001630" }, { "nct_id": "NCT04269551", "title": "A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Autoimmune Haemolytic Anaemia" ], "interventions": [ { "name": "BIVV020", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bioverativ, a Sanofi company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2020-06-15", "completion_date": "2022-01-06", "has_results": false, "last_update_posted_date": "2025-09-22", "last_synced_at": "2026-06-11T07:07:07.153Z", "location_count": 5, "location_summary": "Fayetteville, Georgia • St Louis, Missouri • The Bronx, New York + 2 more", "locations": [ { "city": "Fayetteville", "state": "Georgia" }, { "city": "St Louis", "state": "Missouri" }, { "city": "The Bronx", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04269551" } ] }